Long Island weight loss
From W8MD weight loss and sleep centers
Long Island weight loss options including obesity statistics, GLP-1 injections, medical weight loss, nutrition counseling, sleep medicine, telemedicine, and W8MD support
| Long Island weight loss | |
|---|---|
| W8MD Weight Loss, Sleep and MedSpa helps Long Island patients with physician-supervised medical weight loss, GLP-1 injections, nutrition counseling, sleep medicine, and long-term weight maintenance | |
| Specialty | Obesity medicine, medical weight loss, nutrition counseling, sleep medicine, lifestyle medicine |
| Uses | Obesity, overweight, weight loss, weight loss maintenance, weight regain, insulin resistance, prediabetes, type 2 diabetes, sleep apnea, metabolic syndrome, hypertension
|
| Related | W8MD Weight Loss, Sleep and MedSpa, NYC medical weight loss, Brooklyn weight loss, GLP-1 maintenance therapy, weight loss maintenance |
Long Island weight loss refers to medical, nutritional, behavioral, medication-based, physical activity, sleep, and telemedicine-supported strategies used to help residents of Long Island, New York, lose weight safely and maintain results long term. Long Island includes Nassau County and Suffolk County, as well as the New York City boroughs of Brooklyn and Queens geographically located on the western end of the island. In common regional usage, “Long Island” often refers mainly to Nassau and Suffolk counties.
W8MD Weight Loss, Sleep and MedSpa helps Long Island patients with physician-supervised medical weight loss, affordable GLP-1 weight loss injections, prescription diet pills, nutrition counseling, meal replacements, exercise counseling, sleep apnea screening and treatment, lifestyle medicine, telemedicine follow-up when appropriate, and long-term weight loss maintenance. W8MD's Brooklyn / New York City center is located at 2632 E 21st Street, Suite L3, Brooklyn, NY 11235, phone (718) 946-5500, making it accessible to many Long Island patients from Nassau County, western Suffolk County, Queens, Brooklyn, and the greater New York City region.
Overview
Weight management is a major public health issue for Long Island and New York State. Obesity and overweight are associated with higher risk of type 2 diabetes, prediabetes, hypertension, sleep apnea, heart disease, stroke, fatty liver disease, osteoarthritis, some cancers, reduced mobility, and long-term weight cycling.
In New York State, the Department of Health reports that the percentage of adults with overweight or obesity increased from 42% in 1997 to 64.1% in 2023, while adult obesity increased from 16% in 1997 to 28% in 2023.Obesity Prevention(link). New York State Department of Health. America's Health Rankings reported New York adult obesity at 29.5% in 2024, compared with a U.S. value of 34.2% in the same dataset.Explore Obesity in New York(link). America's Health Rankings.
A comprehensive Long Island weight-loss plan may include:
- Medical weight loss
- GLP-1 weight loss injections
- Semaglutide
- Tirzepatide
- Prescription diet pills
- Nutrition counseling
- Meal replacements
- Low-carbohydrate diet
- Ketogenic diet
- Very low calorie diet
- Exercise counseling
- Behavior modification
- Lifestyle medicine
- Sleep apnea screening
- Home sleep test
- CPAP therapy when indicated
- Telemedicine follow-up when appropriate
- Weight loss maintenance
- Weight regain prevention
Long Island obesity and overweight statistics
Long Island includes diverse communities with different levels of obesity, overweight, diabetes risk, income, food access, walkability, commute patterns, and health-care access. County-level and regional statistics show that obesity and overweight remain common across Nassau and Suffolk counties.
| Area | Latest available statistic | Interpretation | Source |
|---|---|---|---|
| New York State | 64.1% of adults had overweight or obesity in 2023; 28% had obesity | Nearly two-thirds of adults were above the recommended weight range | New York State Department of HealthObesity Prevention(link). New York State Department of Health. |
| New York State | Adult obesity 29.5% in 2024 | Lower than the U.S. average in this dataset, but still a major public health burden | America's Health Rankings / BRFSS 2024Explore Obesity in New York(link). America's Health Rankings. |
| Nassau County | Obesity 26.9% in 2022 | More than 1 in 4 adults had obesity | Data CommonsNassau County(link). Data Commons. |
| Suffolk County | Obesity 29.8% in 2022 | Nearly 3 in 10 adults had obesity | Data CommonsSuffolk County(link). Data Commons. |
| Long Island region | Older regional reporting found Suffolk County had higher percentages of adults with obesity and overweight or obesity than Nassau County | Suggests county-level variation and need for local access to treatment | Long Island Health Collaborative obesity reportObesity in the Long Island Region(link). Long Island Health Collaborative. |
| United States | Adult obesity 40.3% during August 2021-August 2023 | National obesity remains high; severe obesity increased over time | CDC National Center for Health StatisticsObesity and Severe Obesity Prevalence in Adults: United States, August 2021-August 2023(link). Centers for Disease Control and Prevention.September 24, 2024. |
| United States regions | In 2024, the Northeast adult obesity prevalence was 30.3% | Long Island is part of the Northeast region | CDC BRFSS Adult Obesity Prevalence MapsAdult Obesity Prevalence Maps(link). Centers for Disease Control and Prevention.December 3, 2025. |
Why Long Island residents seek medical weight loss
Many Long Island residents seek medical weight loss because diet and exercise alone often do not overcome hunger biology, insulin resistance, stress, sleep deprivation, commute schedules, work demands, medication effects, and weight-regain physiology. Obesity is a chronic and relapsing disease, not simply a willpower problem.
Common reasons to seek help include:
- Difficulty losing weight despite dieting
- Repeated weight regain
- Strong hunger or cravings
- Food noise
- Emotional eating
- Night eating
- Insulin resistance
- Prediabetes
- Type 2 diabetes
- Sleep apnea
- Hypertension
- PCOS
- Fatty liver disease
- Joint pain
- Medication-related weight gain
- Need for GLP-1 prescription support
- Need for long-term maintenance
How W8MD can help Long Island patients
W8MD Weight Loss, Sleep and MedSpa provides physician-supervised care that addresses both weight loss and the medical conditions that commonly accompany obesity and overweight.
W8MD can help Long Island patients with:
- Initial medical weight-loss evaluation
- Body mass index assessment
- Weight-related risk assessment
- Review of medications that may affect weight
- GLP-1 weight loss injections
- Semaglutide programs
- Tirzepatide programs
- Prescription diet pills
- Phentermine
- Contrave
- Qsymia
- Diethylpropion
- Phendimetrazine
- Metformin
- Topiramate
- Orlistat
- Meal replacements
- Nutrition counseling
- Exercise counseling
- Behavior modification
- Sleep apnea screening
- Home sleep test
- CPAP support
- Long-term maintenance planning
In-person and telemedicine options
W8MD may help Long Island residents through both in-person and telemedicine-supported care when clinically appropriate.
In-person care
In-person visits may be useful for:
- Initial medical evaluation
- Blood pressure check
- Weight and body composition review
- Medication safety review
- Injectable medication teaching
- Sleep apnea evaluation
- Laboratory coordination
- MedSpa and body-contouring services
- Patients who prefer face-to-face care
W8MD’s Brooklyn / New York City office is especially accessible to patients from Nassau County, Queens, Brooklyn, and western Suffolk County.
Telemedicine follow-up
Telemedicine or televisit care may be useful for selected Long Island patients who cannot travel frequently.
Telemedicine may help with:
- Weight-loss follow-up
- Medication monitoring
- GLP-1 side-effect review
- Nutrition counseling
- Meal plan adjustment
- Exercise counseling
- Sleep symptom review
- Weight regain prevention
- Maintenance planning
Telemedicine availability depends on patient location, medical condition, state rules, insurance coverage, medication regulations, and clinical judgment. Some patients may still need in-person evaluation, laboratory testing, blood pressure monitoring, or coordination with local clinicians.
Affordable GLP-1 weight loss options for Long Island
Affordable GLP-1 weight-loss options for Long Island residents
W8MD offers physician-supervised GLP-1 weight-loss options for eligible patients from Long Island and the greater New York City region.
- Semaglutide starting as low as $29.99/week and up with insurance for qualifying medical visits.
- Tirzepatide starting as low as $45.00/week and up with insurance for qualifying medical visits.
- Self-pay GLP-1 options may start from $59.99/week and up when available and medically appropriate.
- Most insurances are accepted for qualifying physician-supervised visits when coverage is available.
- Pricing, eligibility, medication access, dosing, insurance coverage, prior authorization, pharmacy availability, telemedicine availability, and program details vary by patient, medication, location, and medical evaluation.
GLP-1 weight loss medications
GLP-1 weight loss injections and related incretin medications can help eligible patients reduce hunger, increase satiety, reduce cravings, reduce food noise, and improve portion control.
Common options include:
| Medication | Brand names | Type | W8MD role |
|---|---|---|---|
| Semaglutide | Wegovy, Ozempic | GLP-1 receptor agonist | May be used for eligible patients when medically appropriate |
| Tirzepatide | Zepbound, Mounjaro | Dual GIP and GLP-1 receptor agonist | May be used for eligible patients when medically appropriate |
| Liraglutide | Saxenda, Victoza | GLP-1 receptor agonist | Alternative injectable option in selected patients |
| Retatrutide | Investigational | Triple GIP, GLP-1, and glucagon receptor agonist | Education and pipeline monitoring only unless legally available |
The FDA approved Zepbound or tirzepatide for chronic weight management in adults with obesity or overweight with at least one weight-related condition, together with reduced-calorie diet and increased physical activity.FDA Approves New Medication for Chronic Weight Management(link). U.S. Food and Drug Administration.November 8, 2023.
The FDA approved Wegovy or semaglutide to reduce the risk of major adverse cardiovascular events in adults with established cardiovascular disease and either obesity or overweight.FDA Approves First Treatment to Reduce Risk of Serious Heart Problems Specifically in Adults with Obesity or Overweight(link). U.S. Food and Drug Administration.March 8, 2024.
Traditional prescription diet pills
GLP-1 medications are not the only option. W8MD may offer traditional prescription weight-loss medications when medically appropriate.
Options may include:
The National Institute of Diabetes and Digestive and Kidney Diseases lists several prescription medications used to treat overweight and obesity, including orlistat, phentermine/topiramate, naltrexone/bupropion, liraglutide, semaglutide, and tirzepatide.Prescription Medications to Treat Overweight and Obesity(link). National Institute of Diabetes and Digestive and Kidney Diseases.
Nutrition counseling
Nutrition counseling is central to safe and sustainable weight loss. W8MD can help Long Island patients build realistic meal plans instead of relying on short-term dieting.
Nutrition counseling may include:
- Protein-first meals
- Low-carbohydrate meal planning
- Ketogenic diet
- Very low calorie diet when medically appropriate
- Meal replacements
- Diabetes-friendly nutrition
- Carbohydrate counting
- Restaurant strategies
- Grocery planning
- Hydration planning
- Cultural food planning
- Weight regain prevention
The NIDDK recommends choosing a safe weight-loss program that includes healthy eating, physical activity, behavior-change strategies, trained staff, medical care when needed, and a long-term plan for keeping weight off.Choosing a Safe and Successful Weight-loss Program(link). National Institute of Diabetes and Digestive and Kidney Diseases.
Meal replacements
Meal replacements may help selected Long Island patients by improving structure, portion control, protein intake, convenience, and consistency.
Meal replacements may help with:
- Busy schedules
- Long commutes
- Skipped meals
- Portion control
- Protein intake
- Low-carbohydrate plans
- GLP-1 patients with low appetite
- Very low calorie diet plans
- Travel days
- Weight regain correction
- Maintenance planning
Exercise counseling
Exercise counseling helps Long Island patients use physical activity safely and realistically. Exercise is important for heart health, insulin sensitivity, strength, mobility, mood, sleep, and long-term maintenance, although nutrition and medications often have a larger role in active weight loss.
W8MD exercise counseling may include:
- Walking plans
- Post-meal walking
- Step goals
- Strength training
- Resistance bands
- Chair exercises
- Low-impact activity
- Joint-friendly movement
- Gradual progression
- Activity planning around work, commuting, and family schedules
The CDC recommends at least 150 minutes of moderate-intensity aerobic activity weekly plus 2 days of muscle-strengthening activity for adults.Adult Activity: An Overview(link). Centers for Disease Control and Prevention.December 20, 2023.
Sleep medicine and sleep apnea
W8MD is also a sleep medicine center. This is especially important because untreated sleep apnea can worsen fatigue, cravings, insulin resistance, hypertension, and weight regain.
W8MD may help Long Island residents with:
- Sleep apnea screening
- Snoring evaluation
- Home sleep test
- CPAP
- BiPAP
- APAP
- Sleep and weight counseling
- Zepbound evaluation for eligible adults with obesity and moderate-to-severe OSA
The FDA approved Zepbound as the first medication for moderate-to-severe obstructive sleep apnea in adults with obesity.FDA Approves First Medication for Obstructive Sleep Apnea(link). U.S. Food and Drug Administration.December 20, 2024.
Weight loss maintenance
Long-term success requires a maintenance plan. Many patients lose weight but regain it when follow-up stops, medication access changes, sleep worsens, stress increases, or old eating habits return.
W8MD maintenance care may include:
- Regular follow-up visits
- Telemedicine follow-up when appropriate
- GLP-1 maintenance therapy
- Clinician-guided microdosing discussions when appropriate
- Prescription diet pills when appropriate
- Nutrition counseling
- Meal replacements
- Exercise counseling
- Strength training
- Sleep apnea treatment
- Weekly weight monitoring
- Relapse prevention
- Early treatment of weight regain
The STEP 1 trial extension found that after withdrawal of once-weekly semaglutide 2.4 mg and lifestyle intervention, participants regained a substantial portion of lost weight."Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension".Diabetes, Obesity and Metabolism.2022;PMID:35441470.PMC:9542252.
The SURMOUNT-4 trial found that continued tirzepatide helped maintain and increase weight reduction, while medication withdrawal led to substantial regain."Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity".JAMA.2024;PMID:38078870.
Long Island communities served
W8MD can help patients from many Long Island communities, including:
- Hempstead
- Garden City
- Mineola
- Great Neck
- Manhasset
- Port Washington
- Roslyn
- Westbury
- Hicksville
- Levittown
- Freeport
- Baldwin
- Rockville Centre
- Long Beach
- Massapequa
- Farmingdale
- Plainview
- Syosset
- Huntington
- Huntington Station
- Melville
- Dix Hills
- Smithtown
- Commack
- Brentwood
- Central Islip
- Bay Shore
- Islip
- Patchogue
- Medford
- Ronkonkoma
- Riverhead
- Southampton
- East Hampton
- Montauk
Why choose W8MD for Long Island weight loss?
W8MD is a natural choice for Long Island residents seeking physician-supervised weight loss because it combines evidence-based obesity medicine with sleep medicine, nutrition counseling, medications, telemedicine follow-up when appropriate, and long-term support.
Reasons to choose W8MD include:
- Physician-supervised care
- Over 15 years of medical weight-loss experience
- Affordable GLP-1 options
- Semaglutide and Tirzepatide programs
- Traditional prescription diet pills
- Nutrition counseling
- Meal replacement options
- Sleep apnea diagnosis and treatment
- Weight-loss maintenance planning
- Weight regain prevention
- In-person Brooklyn / NYC visits
- Telemedicine follow-up options when appropriate
- Most insurances accepted for qualifying visits
- Practical long-term follow-up
W8MD patient success highlight
W8MD has helped thousands of patients since 2011. Individual results vary, but W8MD success stories include patients who lost more than 100 pounds and maintained long-term results.
Fantastic program. Truly a life changer.
“FANTASTIC program! Truly a life changer! The first several months I lost on average 3 pounds a week. I have now lost 87 pounds in 10 months and I'm still losing! I can say it feels almost effortless, for with the elimination of most carbs plus the medication I have ZERO cravings and minimal hunger. My cholesterol, blood pressure, and blood sugar have all returned to normal having previously been considerably elevated. I look and feel twenty years younger (I am 57.) Staff is friendly and supportive, and the science works. I did not think that I would be able to achieve such results, and certainly not in less than a year. I am amazed at my success, and I could not have done it without Dr. Tumpati and W8MD.”
- D.M., actual W8MD patient who lost 100 lbs and has maintained the weight loss for over 10 years. Individual results vary.
W8MD Brooklyn / New York City location
| Location | Address | Phone | Services | Map |
|---|---|---|---|---|
| Brooklyn / New York City Weight Loss and MedSpa Center | 2632 E 21st Street, Suite L3, Brooklyn, NY 11235 | (718) 946-5500 | Medical weight loss, GLP-1 weight loss injections, Semaglutide, Tirzepatide, nutrition counseling, exercise counseling, sleep medicine, MedSpa, weight loss maintenance, telemedicine follow-up when appropriate | View map |
Frequently asked questions
Does W8MD help Long Island residents lose weight?
Yes. W8MD can help Long Island residents through its Brooklyn / New York City medical weight-loss program, including GLP-1 options, traditional diet pills, nutrition counseling, meal replacements, sleep medicine, and long-term maintenance care.
Does W8MD offer telemedicine for Long Island patients?
W8MD may offer telemedicine or televisit follow-up options when clinically appropriate and permitted by state rules, insurance coverage, and medication regulations. Some patients may still need in-person evaluation.
What are the latest Long Island obesity statistics?
Data Commons reported obesity at 26.9% in Nassau County and 29.8% in Suffolk County in 2022. New York State reported that 64.1% of adults had overweight or obesity and 28% had obesity in 2023.
What GLP-1 shots are available for Long Island patients?
Eligible patients may be evaluated for Semaglutide, Tirzepatide, and other medically appropriate GLP-1 or incretin-based options. Medication choice depends on medical history, BMI, insurance, contraindications, availability, and clinician judgment.
How much do GLP-1 weight loss shots cost at W8MD?
W8MD promotional pricing may include Semaglutide starting as low as $29.99/week and up with insurance for qualifying visits and Tirzepatide starting as low as $45.00/week and up with insurance for qualifying visits. Pricing and eligibility vary.
Does W8MD offer non-GLP-1 weight-loss medications?
Yes. W8MD may offer traditional prescription diet pills such as Phentermine, Contrave, Qsymia, Diethylpropion, Phendimetrazine, Topiramate, Metformin, or Orlistat when medically appropriate.
Can W8MD help with weight regain?
Yes. W8MD focuses on long-term weight maintenance, medication adjustment, nutrition counseling, regular follow-up, sleep apnea treatment, exercise counseling, and early intervention for regain.
Can W8MD help if I have sleep apnea?
Yes. W8MD provides sleep apnea screening, home sleep testing, CPAP-related support, and weight-loss care for patients with obesity and sleep apnea risk.
Conclusion
Long Island weight loss requires more than a short-term diet. With obesity affecting more than one-quarter of adults in Nassau County and nearly three in ten adults in Suffolk County, and with New York State reporting that 64.1% of adults had overweight or obesity in 2023, there is a strong need for safe, evidence-based, medically supervised weight management. W8MD Weight Loss, Sleep and MedSpa can help Long Island residents through in-person Brooklyn / New York City visits and telemedicine follow-up when appropriate, combining GLP-1 injections, traditional prescription diet pills, nutrition counseling, meal replacements, exercise counseling, sleep apnea care, behavior modification, and long-term maintenance strategies to help patients lose weight and keep it off.
See also
- Long Island weight loss
- NYC medical weight loss
- Brooklyn weight loss
- New York City weight loss
- Nassau County weight loss
- Suffolk County weight loss
- Medical weight loss
- Obesity medicine
- GLP-1 weight loss injections
- Semaglutide
- Tirzepatide
- Zepbound
- Wegovy
- Diet pills
- Phentermine
- Contrave
- Nutrition counseling
- Meal replacements
- Exercise counseling
- Sleep apnea
- Telemedicine
- Weight loss maintenance
- Weight regain
- W8MD Weight Loss, Sleep and MedSpa
Relevant WikiMD links
- Long Island weight loss on WikiMD
- NYC medical weight loss on WikiMD
- Brooklyn weight loss on WikiMD
- Medical weight loss on WikiMD
- GLP-1 weight loss injections on WikiMD
- Semaglutide on WikiMD
- Tirzepatide on WikiMD
- Nutrition counseling on WikiMD
- Sleep apnea on WikiMD
- Telemedicine on WikiMD
- Weight loss maintenance on WikiMD
Further reading
- Obesity Prevention(link). New York State Department of Health.
- Explore Obesity in New York(link). America's Health Rankings.
- Nassau County(link). Data Commons.
- Suffolk County(link). Data Commons.
- Obesity in the Long Island Region(link). Long Island Health Collaborative.
- Obesity and Severe Obesity Prevalence in Adults: United States, August 2021-August 2023(link). Centers for Disease Control and Prevention, National Center for Health Statistics.September 24, 2024.
- Adult Obesity Prevalence Maps(link). Centers for Disease Control and Prevention.December 3, 2025.
- Prescription Medications to Treat Overweight and Obesity(link). National Institute of Diabetes and Digestive and Kidney Diseases.
- Choosing a Safe and Successful Weight-loss Program(link). National Institute of Diabetes and Digestive and Kidney Diseases.
- Adult Activity: An Overview(link). Centers for Disease Control and Prevention.December 20, 2023.
- FDA Approves New Medication for Chronic Weight Management(link). U.S. Food and Drug Administration.November 8, 2023.
- FDA Approves First Treatment to Reduce Risk of Serious Heart Problems Specifically in Adults with Obesity or Overweight(link). U.S. Food and Drug Administration.March 8, 2024.
- FDA Approves First Medication for Obstructive Sleep Apnea(link). U.S. Food and Drug Administration.December 20, 2024.
- "Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension".Diabetes, Obesity and Metabolism.2022;PMID:35441470.PMC:9542252.
- "Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity".JAMA.2024;PMID:38078870.
External links
- NYC medical weight loss
- W8MD Weight Loss, Sleep and MedSpa Centers
- W8MD Philadelphia medical weight loss
- Long Island weight loss on WikiMD
- NYC medical weight loss on WikiMD
- Medical weight loss on WikiMD
- GLP-1 weight loss injections on WikiMD
- Telemedicine on WikiMD
- Weight loss maintenance on WikiMD
| W8MD Weight Loss, Sleep and MedSpa | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
| GLP-1 receptor agonists, incretin therapy, and weight loss medications | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
